How many doses of epinephrine can be given during a cardiac arrest code?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Epinephrine Dosing in Cardiac Arrest

There is no maximum number of doses of epinephrine during a cardiac arrest code—you continue giving 1 mg IV/IO every 3-5 minutes until return of spontaneous circulation (ROSC), termination of resuscitation efforts, or transition to extracorporeal CPR (ECPR). 1

Standard Dosing Protocol

The current American Heart Association guidelines are clear and consistent across all iterations:

  • Adult dose: 1 mg IV/IO every 3-5 minutes 1, 2, 3
  • Pediatric dose: 0.01 mg/kg (maximum 1 mg) every 3-5 minutes 4
  • Operationally: Administer every second cycle of CPR after the initial dose 3

Timing Considerations by Rhythm

Shockable Rhythms (VF/pVT)

  • Prioritize defibrillation and CPR first 2, 3
  • Give epinephrine after initial attempts with CPR and defibrillation are unsuccessful 2
  • Typically administered after the third shock in trial protocols 3
  • One observational study showed 10% lower survival in hospitals with highest rates of epinephrine before initial defibrillation 2

Nonshockable Rhythms (Asystole/PEA)

  • Administer epinephrine as soon as feasible once IV/IO access is obtained 5, 6
  • Earlier administration (1-3 minutes) associated with increased ROSC and neurologically intact survival 5

Critical Evidence Nuances

The Epinephrine Paradox

While epinephrine consistently improves ROSC and short-term survival, it does not improve survival with favorable neurologic outcome 5, 2, 3, 7, 6. The landmark PARAMEDIC2 trial showed:

  • Improved ROSC and survival to hospital admission
  • No significant difference in 3-month survival with favorable neurologic outcome
  • Median time to epinephrine was 21 minutes—this delay may explain poor neurologic outcomes 3

Cumulative Dose Concerns

Recent evidence suggests potential harm with excessive dosing:

  • Cumulative doses >3 mg consistently associated with poor neurologic outcomes, particularly in ECPR patients 8, 7
  • One study showed unfavorable neurologic outcomes with odds ratio 4.6 (95% CI 1.3-18.0) when doses exceeded 3 mg 8
  • However, guidelines do not specify a maximum cumulative dose 2

High-Dose Epinephrine

Multiple trials comparing high-dose (0.1-0.2 mg/kg or 5-10 mg) versus standard-dose epinephrine show:

  • No benefit for survival to discharge or neurologic outcomes 5, 9, 6
  • Possible increased ROSC but potentially worse outcomes 5, 9
  • Not recommended except in special circumstances (β-blocker overdose, calcium channel blocker overdose) 4

Practical Algorithm

  1. Establish IV/IO access during CPR
  2. For shockable rhythms: Give first epinephrine dose after initial defibrillation attempts fail
  3. For nonshockable rhythms: Give first epinephrine dose as soon as access obtained
  4. Continue 1 mg every 3-5 minutes (every second CPR cycle) throughout resuscitation
  5. No arbitrary stopping point—continue until ROSC, termination of efforts, or ECPR initiation
  6. Consider cumulative dose if approaching ECPR—doses >3 mg may portend worse neurologic outcomes

Common Pitfalls

  • Delaying epinephrine in nonshockable rhythms: Earlier is better for these patients 5
  • Giving epinephrine before defibrillation in shockable rhythms: Prioritize shocks first 2, 3
  • Using high-dose protocols: No evidence of benefit, possible harm 5, 9
  • Stopping at arbitrary dose limits: Guidelines specify no maximum, though emerging evidence suggests caution with cumulative doses >3 mg 2, 8

Alternative Agents (Not Recommended)

  • Vasopressin alone or combined with epinephrine: No advantage over standard-dose epinephrine 5, 2, 6
  • Vasopressin + methylprednisolone: One trial showed increased ROSC in in-hospital cardiac arrest but no difference in survival or neurologic outcomes 3

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.